Atopic Dermatitis

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Latest News

Pediatric atopic dermatitis | Image Credit: Maggie L. Shaw/sora.chatgpt.com
Pediatric Atopic Dermatitis Linked to Allergy Development

June 13th 2025

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth cohorts from the Environmental Influences on Child Health Outcomes Children’s Respiratory and Environmental Workgroup.

Atopic Dermatitis Image Credit: wladimir1804-stock.adobe.com
Oral Ivarmacitinib Shows Promise in Atopic Dermatitis

June 6th 2025

Through data from genome-wide association studies, the researchers identified several single nucleotide polymorphisms contributing to the causal relationship between insomnia and atopic dermatitis. | Image credit: amenic181 - stock.adobe.com
Study Explores Link Between Insomnia, Atopic Dermatitis

May 31st 2025

The apparent divergence between subjective and objective measures of atopic dermatitis severity underscores the need for more precise assessment methods, the authors explained. | Image credit: Evgeniya Primavera - stock.adobe.com
AI Model Can Help Classify Atopic Dermatitis Lesion Severity

May 29th 2025

Adolescent patients were more likely to be most bothered by feelings of anxiety or atopic dermatitis affecting their daily activities. | Image Credit: InfiniteStudio - stock.adobe.com
Patient-Reported Experiences Show Psychological Impact of Atopic Dermatitis on Adolescents

May 22nd 2025

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo